A rare case of breakthrough fungal pericarditis due to fluconazole‐resistant Candida auris in a patient with chronic liver disease
Open Access
- 1 September 2014
- journal article
- Published by Microbiology Society in JMM Case Reports
- Vol. 1 (3)
Abstract
Introduction: Candida pericarditis is a rare clinical entity with a high fatality, primarily attributed to difficulty in diagnosis. Unfortunately, the diagnosis is made post‐mortem in more than 50% of cases, and thus a high index of clinical suspicion is crucial. Case presentation: We report a rare case of fungal pericardial effusion caused by the recently recognized multidrug‐resistant Candida auris, which was cultured from pericardial fluid, blood, bronchoalveolar lavage and urine of a chronic liver disease patient while on empiric fluconazole therapy. The yeast was misidentified as Candida haemulonii by the VITEK2 commercial identification system, and was confirmed as C. auris by internal transcribed spacer and large ribosomal subunit sequencing. In addition, the VITEK2 AST card erroneously revealed a high amphotericin B MIC (16 µg ml−1) and low caspofungin MIC (0.25 µg ml−1) that did not correlate with results from the reference Clinical and Laboratory Standards Institute (CLSI) microbroth dilution method. Based on VITEK2 MIC data, the patient was administered caspofungin. However, in vitro antifungal susceptibility data for C. auris by the CLSI method exhibited high MICs to fluconazole (64 µg ml−1) and caspofungin MIC (1 µg ml−1) but low MICs to amphotericin B (MIC range, 0.125−0.5 µg ml−1). The patient’s repeat pericardial fluid culture, despite caspofungin therapy for 12 days, grew C. auris and he died on day 13 of therapy. Conclusion: C. auris is a recently reported agent of fungaemia and deep‐seated infections and is notable for its antifungal resistance. Although early species identification and rapid antifungal susceptibility testing are needed in cases of critical infections, the reporting of rare yeast isolates exhibiting high MICs to antifungals by automated systems needs a cautionary approach.Keywords
This publication has 27 references indexed in Scilit:
- Candida auris –Associated Candidemia, South AfricaEmerging Infectious Diseases, 2014
- Multidrug-resistant endemic clonal strain of Candida auris in IndiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?Antimicrobial Agents and Chemotherapy, 2013
- New Clonal Strain of Candida auris , Delhi, IndiaEmerging Infectious Diseases, 2013
- Cardiac tamponnade likely due to candida infection, in an immuno-competent patientAnnales de Cardiologie et d'Angéiologie, 2013
- Successful management of fungal pericarditis and endocarditis in a neonate: A case reportJournal of the Saudi Heart Association, 2012
- EUCAST technical note on anidulafunginClinical Microbiology and Infection, 2011
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida aurisJournal of Clinical Microbiology, 2011
- Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical FeaturesClinical Infectious Diseases, 2009
- Purulent Pericarditis Caused by Candida: Report of Three Cases and Identification of High-Risk Populations as an Aid to Early DiagnosisClinical Infectious Diseases, 1988